Rolling out antiretrovirals in Africa: There are still challenges ahead

被引：17

作者：

Colebunders, R

Ronald, A

Katabira, E

Sande, M

机构：

[1] Makerere Univ, Infect Dis Inst, Kampala, Uganda

[2] Academ Alliance AIDS Care & Prevent Africa, Kampala, Uganda

[3] Inst Trop Med, Antwerp, Belgium

[4] Univ Antwerp, B-2020 Antwerp, Belgium

[5] Univ Manitoba, Winnipeg, MB R3T 2N2, Canada

[6] Univ Utah, Sch Med, Salt Lake City, UT 84112 USA

来源：

CLINICAL INFECTIOUS DISEASES | 2005年 / 41卷 / 03期

关键词：

D O I：

10.1086/431490

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：386 / 389

页数：4

共 21 条

[1] Lessons learned from use of highly active antiretroviral therapy in Africa [J].

Akileswaran, C ;

Lurie, MN ;

Flanigan, TP ;

Mayer, KH .

CLINICAL INFECTIOUS DISEASES, 2005, 41 (03) :376-385

[2]

[Anonymous], 2004, SCAL ANT THER RES LT

[3] Hepatotoxicity associated with nevirapine use [J].

Baylor, MS ;

Johann-Liang, R .

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2004, 35 (05) :538-539

[4] The etiology of severe anemia in a village and a periurban area in Mali [J].

Dicko, A ;

Klion, AD ;

Théra, MA ;

Sagara, I ;

Yalcouyé, D ;

Niambele, MB ;

Sogoba, M ;

Dolo, G ;

Dao, A ;

Diallo, DA ;

Doumbo, OK ;

Miller, LH .

BLOOD, 2004, 104 (04) :1198-1200

[5] Comparison of nevirapine (NVP) resistance in Ugandan women 7 days vs. 6-8 weeks after single-dose NVP prophylaxis: HIVNET 012 [J].

Eshleman, SH ;

Guay, LA ;

Mwatha, A ;

Cunningham, SP ;

Brown, ER ;

Musoke, P ;

Mmiro, F ;

Jackson, JB .

AIDS RESEARCH AND HUMAN RETROVIRUSES, 2004, 20 (06) :595-599

[6] Characterization of nevirapine resistance mutations in women with subtype A vs. D HIV-1 6-8 weeks after single-dose nevirapine (HIVNET 012) [J].

Eshleman, SH ;

Guay, LA ;

Mwatha, A ;

Brown, ER ;

Cunningham, SP ;

Musoke, P ;

Mmiro, F ;

Jackson, JB .

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2004, 35 (02) :126-130

[7] Maternal toxicity with continuous nevirapine in pregnancy - Results from PACTG 1022 [J].

Hitti, J ;

Frenkel, LM ;

Stek, AM ;

Nachman, SA ;

Baker, D ;

Gonzalez-Garcia, A ;

Provisor, A ;

Thorpe, EM ;

Paul, ME ;

Foca, M ;

Gandia, J ;

Huang, S ;

Wei, LJ ;

Stevens, LM ;

Watts, DH ;

McNamara, J .

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2004, 36 (03) :772-776

[8] Intrapartum exposure to nevirapine and subsequent maternal responses to nevirapine-based antiretroviral therapy [J].

Jourdain, G ;

Ngo-Giang-Huong, N ;

Le Coeur, S ;

Bowonwatanuwong, C ;

Kantipong, P ;

Leechanachai, P ;

Ariyadej, S ;

Leenasirimakul, P ;

Hammer, S ;

Lallemant, M .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (03) :229-240

[9] Scaling up access to antiretroviral treatment in southern Africa: who will do the job? [J].

Kober, K ;

Van Damme, W .

LANCET, 2004, 364 (9428) :103-107

[10] Incomplete immune reconstitution after initiation of highly active antiretroviral therapy in human immunodeficiency virus-infected patients with severe CD4+ cell depletion [J].

Lederman, HM ;

Williams, PL ;

Wu, JW ;

Evans, TG ;

Cohn, SE ;

McCutchan, JA ;

Koletar, SL ;

Hafner, R ;

Connick, E ;

Valentine, FT ;

McElrath, MJ ;

Roberts, NJ ;

Currier, JS .

JOURNAL OF INFECTIOUS DISEASES, 2003, 188 (12) :1794-1803

← 1 2 3 →